• Product NameEpimedin C
• Brief DescriptionInhibitors
• Purification99.11%
• Biological ActivityEpimedin C was metabolized via desugarization, dehydrogenation, hydrogenation, dehydroxylation, hydroxylation, demethylation and glucuronidation pathways in vivo. It has potential activity against osteoporosis by stimulating osteoblasts.
• Target NameOthers
• CAS No. 110642-44-9
• Calculated MW 822.8
• Formulation C39H50O19
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Others
  SMILES:C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)O[C@@H]2[C@@H]([C@H]([C@@H](O[C@H]2OC3=C(OC4=C(C3=O)C(=CC(=C4CC=C(C)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)C6=CC=C(C=C6)OC)C)O)O)O)O)O
  Pathways:Others
  Receptor:Others
  Boling pt:
  Melting pt:
  Solubility:Pyridine, Methanol, Ethanol, etc.
  Appearance:Yellow powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Cui L, et al. Biomed Chromatogr. 2014 Oct;28(10):1306-12.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting